Literature DB >> 28285976

High altitude illness in pilgrims after rapid ascent to 4380 M.

Ken Zafren1, Matiram Pun2, Nirajan Regmi2, Gobinda Bashyal3, Bhuwan Acharya3, Subarna Gautam2, Sujan Jamarkattel2, Shankar Raj Lamichhane2, Suman Acharya2, Buddha Basnyat4.   

Abstract

BACKGROUND: The goal of the study was to characterize high altitude illness in Nepali pilgrims.
METHODS: We kept standardized records at the Himalayan Rescue Association (HRA) Temporary Health Camp at Gosainkund Lake (4380 m) in the Nepal Himalaya during the annual Janai Purnima Festival in 2014. Records included rate of ascent and Lake Louise Score (LLS). We defined High Altitude Headache (HAH) as headache alone or LLS = 2. Acute Mountain Sickness (AMS) was LLS≥3. High Altitude Cerebral Edema (HACE) was AMS with ataxia or altered mental status.
RESULTS: An estimated 10,000 pilgrims ascended rapidly, most in 1-2 days, from Dhunche (1960 m) to Gosainkund Lake (4380 m). We saw 769 patients, of whom 86 had HAH. There were 226 patients with AMS, including 11 patients with HACE. We treated patients with HACE using dexamethasone and supplemental oxygen prior to rapid descent. Each patient with HACE descended carried by a porter. There were no fatalities due to HACE. There were no cases of High Altitude Pulmonary Edema (HAPE).
CONCLUSIONS: HAH and AMS were common in pilgrims ascending rapidly to 4380 m. There were 11 cases of HACE, treated with dexamethasone, supplemental oxygen and descent. There were no fatalities.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute mountain sickness; Altitude sickness; High altitude cerebral edema; High altitude pulmonary edema; Hypoxia; Pilgrims

Mesh:

Substances:

Year:  2017        PMID: 28285976     DOI: 10.1016/j.tmaid.2017.03.002

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  3 in total

1.  Plateau hypoxia attenuates the metabolic activity of intestinal flora to enhance the bioavailability of nifedipine.

Authors:  Juanhong Zhang; Yuyan Chen; Yuemei Sun; Rong Wang; Junmin Zhang; Zhengping Jia
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

2.  High-altitude illness: Menace in Himalayas of Nepal.

Authors:  Saral Lamichhane; Ishwor Ghimire; Amrit Pokhrel; Nava Raj Sharma; Surya Kiran Acharya
Journal:  Ann Med Surg (Lond)       Date:  2022-08-24

3.  Association of EPAS1 and PPARA Gene Polymorphisms with High-Altitude Headache in Chinese Han Population.

Authors:  Yang Shen; Jihang Zhang; Jie Yang; Chuan Liu; Shizhu Bian; Chen Zhang; Jie Yu; Xubin Gao; Lan Huang
Journal:  Biomed Res Int       Date:  2020-02-24       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.